Brazil, China and India in the global value chains of pharmaceutical industry
DOI:
https://doi.org/10.11606/0103-2070.ts.2023.216453Keywords:
Global Value Chains, Pharmaceutical Industry, Brazil, China, IndiaAbstract
The main purpose of this article is to investigate the evolution of China, Brazil and India participation in the pharmaceutical global value chains and how the development of their respective pharmaceutical industries impacted their positioning during the Covid-19 pandemic. The object of this research will be the State policies implemented in order to develop the pharmaceutical sector in the countries analyzed, as well as the impacts on its international insertion between 1980 and 2022. The article adopts the analytical framework of global value chains, which explains the division of production processes across different States and the concentration of production of intangible assets with high added value (such as technology and intellectual property) in important nodes (countries) of a given chain. In this sense, we propose the following research questions: how does the insertion of China, India and Brazil occur in global value chains in this sector? Which nodes did they manage to occupy? Answering these questions allows us to assess whether the international insertion of these countries took place in a subordinate manner or with a greater degree of autonomy and governance in the pharmaceutical chains. Finally, an analysis will be carried out of how the development of the pharmaceutical industry in the selected countries impacted their position in relation to the global pharmaceutical industry
Downloads
References
ABIFINA. (abr. 2022), "Química fina: crescimento depende de políticas e investimentos de longo prazo". Facto, [s. l], v. 68, n. 15, p. 45-50, abr. 2022. ISSN 2623-1177. Disponível em: https://abifina.org.br/facto/68/destaque/quimica-fina-crescimento-depende-de-politicas-e-investimentos-de-longo-prazo/. Acesso em: 15 jul. 2023.
ABIQUIFI. (2023), "O custo do atraso: Brasil produz apenas 5% dos insumos de medicamentos". Associação Brasileira da Indústria de Insumos Farmacêuticos. Disponível em: https://abiquifi.org.br/o-custo-do-atraso-brasil-produz-apenas-5-dos-insumos-de-medicamentos/. Acesso em: 15 jul. 2023.
AGÊNCIA SENADO. (6 de maio 2021), "Aprovado incentivo à indústria farmacêutica nacional: texto vai à câmara". texto vai à Câmara. 2021. Disponível em: https://www12.senado.leg.br/noticias/materias/2021/05/06/aprovado-incentivo-a-industria-farmaceutica-nacional-texto-vai-a-camara. Acesso em: 20 jul. 2023.
AHLUWALIA, Montek S. (2002), “Economic reforms in India since 1991: Has gradualism
worked?”. Journal of Economic Perspectives, 16 (3): 67-88.
ALGAZY, Jeffrey; DEU, Franck Le; LI, Sydnie; ZHANG, Fangning; ZHOU, Josie. (15 ago.
, “Vision 2028: how china could impact the global biopharma industry". Life Sciences Practice. https://www.mckinsey.com/industries/life-sciences/our-insights/vision-2028-how-
-china-could-impact-the-global-biopharma-industry.
BRASIL. (2021), PL 4209/2019. Disponível em: https://www.camara.leg.br/proposicoesWeb/fichadetramitacao?idProposicao=2282748, consultado em 23/08/2023.
CASTRO, Elza Moreira Marcelino de. (2018), O acordo Trips e a saúde pública: implicações e
perspectivas. Brasília, Funag. 540 p.
CHANDRAN, Nisha & BRAHMACHARI, Samir. (25 mar. 2018), “Policy as a driver of economic
growth: historical evidence from the indian pharmaceutical industry”. Current Science, 114
(6): 1181-1193.
DAXUE. (2022), “China’s pharmaceutical industry will be the world’s largest in less than 10
years”. Daxueconsulting. Disponível em: https://daxueconsulting.com/pharmaceutical-
-industry-china/, consultado em 05/08/2023.
DELGADO, Ignacio Godinho. (2015), “Política industrial para os setores farmacêutico, autoomotivo e têxtil na China, Índia e Brasil”. Ipea. Textos para Discussão 2087. Brasília. issn 1415-4765.
EVENETT, Simon J.; HOEKMAN, Bernard; ROCHA, Nadia & RUTA, Michele. (2021), “The Covid-
Vaccine Production Club: Will value chains temper nationalism?”. World Bank Group
– Macroeconomics, Trade and Investment Global Practice. Policy Research Working Paper 9565.
FRANCULINO, Kleber A. S. & Gomes, Rogério. (2015), “Políticas públicas e competitividade
na indústria farmacêutica: os casos do Brasil e da Índia”. In: Altec 2015. xvi Congresso
Latino-Iberoamericano de Gestão da Tecnolologia, Porto Alegre, 19 a 22 de outubro de
, Anais do Evento.
GADELHA, Carlos Grabois. “Indústria de fármacos no contexto do complexo econômico-
-industrial da saúde 4.0”. (abr. 2021), Facto, Rio de Janeiro, 15 (65): 6-7. Associação Brasileira
das Indústrias de Química Fina, Biotecnologia e suas Especialidades. issn 2623-1177.
GEREFFI, Gary; BAMBER, Penny & FERNANDEZ-STARK, Karina. (2022), “China’s evolving
role in global value chains: upgrading strategies in an era of disruptions and resilience”. In:
GEREFFI, Gary; BAMBER, Penny & FERNANDEZ-STARK, Karina (eds.). China’s New Development Strategies: upgrading from above and from below in global value chains. Singapore, Palgrave Macmillan, pp. 1-25.
GOI, Government of India, Department of Pharmaceuticals Ministry of Chemicals & Fertilizers. (2021), Annual Report 2020-2021.
GRACE, Cheri. (2004), “The effect of changing intellectual property on pharmaceutical industry prospects in India and China: considerations for access to medicines”. Dfid Health Systems Resource Centre – Issues paper – Access to medicines.
GRAHAM, Niels. (2023), “The us is relying more on China for pharmaceuticals – and vice versa”. Atlantic Council – Geoeconomics Center. Disponível em Https://www.atlanticcouncil.org/blogs/econographics/the-us-is-relying-more-on-china-for-pharmaceuticals-and-vice-versa/, consultado em 15/05/2023.
HONCHARENKO, Daria. (31 jul. 2020), “Pharmaceutical industry development: key policy
instruments in China”. Eureka: Social and Humanities, 4: 3-9. Ou Scientific Route. http://
dx.doi.org/10.21303/2504-5571.2020.001369.
HOQUE, Ariful & DAS, Subhrabaran. (27 out. 2021), “Trends in productivity growth of Indian
pharmaceutical industry: a growth accounting analysis”. Journal of Pharmaceutical Research International, 33 (47A): 437-446.
IBEF, India Brand Equity Foundation. (2023), “India is among the top 10 pharmaceutical exporting countries with its share of the global market on the rise compared to the previous 5 years. An initiative of Ministry of Commerce and Industry – Government of India”. India
Brand Equity Foundation. Disponível em: https://www.ibef.org/industry/pharmaceutical-
-india, consultado em 01/05/2023.
INVEST INDIA. (2023), “Snapshot Formulating success: The Indian pharmaceutical industry”.
Disponível em https://www.investindia.gov.in/sector/pharmaceuticals, consultado em
/05/2023.
KAMIIKE, Atsuko. (5 dez. 2019), “The Trips agreement and the pharmaceutical industry in
India”. Journal of Interdisciplinary Economics, 32 (1): 95-113. Sage Publications. http://
dx.doi.org/10.1177/0260107919875573.
KAPILA, Uma. (2008), India’s economic development since 1947. 3. ed. Nova Delhi, Academic
Foundation.
KONG, Linghui; LI, Qiu; KAITIN, Kenneth I. & SHAO, Liming. (2023), “Innovation in the
Chinese pharmaceutical industry”. Nature Reviews Drug Discovery, 22 (1): 12-13. Springer
Science and Business Media llc. http://dx.doi.org/10.1038/d41573-022-00167-2.
KUMAR, Vinod; BANSAL, Vasudha; MADHAVAN, Aravind; KUMAR, Manoj; SINDHU, Raveendran; AWASTHI, Mukesh Kumar; BINOD, Parameswaran & SARAN, Saurabh. (fev. 2022), “Active pharmaceutical ingredient (api) chemicals: a critical review of current biotechnological approaches”. Bioengineered, 13 (2): 4309-4327. Informa uk Limited. http://dx.doi.org/10.1080/21655979.2022.2031412.
LISBOA, Vinícius. (2021), “Agência Brasil explica o que é o ifa”. Agência Brasil. Disponível em:
https://agenciabrasil.ebc.com.br/saude/noticia/2021-02/agencia-brasil-explica-o-que-e-o-
-ifa, consultado em 11/05/2023.
LIU, Haolang. (2021), “The impact of the coronavirus on Chinese pharmaceutical industry”. Advances in Economics, Business and Management Research, 66: 51-56. Atlantis Press B. V.
MAGALHÃES, Luis Carlos Garcia de. (2009), “Controvérsia – A política industrial brasileira e
suas vulnerabilidades: Que política industrial o Brasil precisa?”. Ipea. Disponível em https://
www.ipea.gov.br/desafios/index.php?option=com_content&view=article&id=2272:catid
=28&Itemid=23, consultado em 03/09/2023.
MALACALZA, Bernabé & FAGABURU, Debora. (2022), “¿Empatía o cálculo? Un análisis
crítico de la geopolítica de las vacunas en América Latina”. Foro Internacional, LXII, (1),
cuad. 247: 5-45.
MIRANDA, Caroline; Hasenclever, Lia & Paranhos, Julia. (2022), “Cadeias globais de valor e integração regional na América Latina e Caribe: o caso da indústria farmacêutica pela perspectiva brasileira”. vi Enei – Encontro Nacional de Economia Industrial, 30 maio a
jun. 2022, Anais do Evento, 17 p.
MIROUDOT, Sébastien & Backer, Koen de. (2012), Mapping global value chains. Paris, Organization for Economic Co-Operation and Development. 45 p. Policy Dialogue on Aid
for Trade – oecd, Trade and Agriculture Committee, Trade Committee.
NOVAIS, Luis Fernando; QUINTÃO, Marcelo & CAGNIN, Rafael. (2016), “A indústria farmacêutica no Brasil: evolução recente e desafios futuros”. Carta Iedi 766 – Instituto de
Estudos para o Desenvolvimento Industrial. Disponível em https://www.iedi.org.br/cartas/
carta_iedi_n_766.html, consultado em 03/09/2023.
PONTE, Stefano; GEREFFI, Gary & RAJ-REICHERT, Gale. (2019), “Introduction to the handbook
on global value chains”. In: PONTE, Stefano; GEREFFI, Gary & RAJ-REICHERT, Gale
(eds.). Handbook on global value chains. Cheltenham, Edward Elgar Publishing, pp. 1-28.
RABACH, Eileen & KIM, Eun Mee. (1994), “Where is the chain in commodity chains?: the
service sector nexus”. In: GEREFFI, Gary & KORZENIEWICZ, Miguel (eds.). Commodity
chains and global capitalism. United States of America, Praeger Publishers, pp. 123-141.
RAULT-CHODANKAR, Yves-Marie & KALE, Dinar. (23 maio 2022), “Manufacturers without
factories and economic development in the Global South: India’s pharmaceutical firms”.
Journal of Economic Geography, 23 (2): 319-341. https://doi.org/10.1093/jeg/lbac013.
SINDUSFARMA. (2023), Profile of the pharmaceutical 2023 industry and relevant sector aspects. São Paulo, Sindusfarma, 8 p.
SINGH, Bawa; SINGH, Sandeep; SINGH, Balinder & CHATTU, Vijay Kumar. (17 fev. 2022),
“India’s neighbourhood vaccine diplomacy during Covid-19 pandemic: humanitarian and
geopolitical perspectives”. Journal of Asian and African Studies, 58 (6): 1021-1037. Sage
Publications. http://dx.doi.org/10.1177/00219096221079310.
TORRES, Ricardo L. & HASENCLEVER, Lia. (2017), “A evolução institucional das indústrias
farmacêuticas indiana e brasileira revisitada”. In: História Econômica & História de Empresas, 20 (2): 375-406.
VEUGELERS, Reinhilde; POITIERS, Niclas & GUETTA-JEANRENAUD, Lionel. (2021), “A world divided: global vaccine trade and production”. Bruegel. Disponível em https://www.bruegel.org/blog-post/world-divided-global-vaccine-trade-and-production, consultado em 08/05/2023.
VIEIRA, Fabiola Sulpino & SANTOS, Maria Angelica Borges dos. (2020), O setor farmacêutico
no Brasil sob as lentes da conta-satélite saúde. Texto para discussão / Instituto de Pesquisa
Econômica Aplicada. Brasília; Rio de Janeiro, Ipea, 1990-issn 1415-4765.
WHO. (2022), Global vaccine market report 2022: a shared understanding for equitable access to vaccines. World Health Organization.
WHO. (2023), Global vaccine market report. Geneva, Market Information for Access to Vaccines.
World Health Organization. World Integrated Trade Solution (Wits). (2023), World Bank. Disponível em www.wits.worldbank. org, consultado em 08/11/2023.
ZHONG, Jianli. (17 fev. 2022), “Transforming the pharma industry”. Science and Technology
Daily. Beijing, pp. 2-2.
ZUCOLOTO, Graziela Ferrero. (2013), Patenteamento em biotecnologias: a experiência chinesa. Texto para discussão / Instituto de Pesquisa Econômica Aplicada. Brasília; Rio de Janeiro, Ipea, 1990- issn 1415-4765.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Helton, Daniela
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
